Medicinal cannabis in Germany - Business Report

7 Confidential __________________________________________________________________________________ ket segments such as dietary supplements and novel food products as well as cosmetic products and consumer products with Cannabis as an essential ingredient are considered. From the current market analysis and situation in Germany, a detailed forecast of the develop- ment in the next five years is then presented. This prognosis of the Cannabis market in Germany is integrally differentiated across all Cannabis products on the one hand and by market segments such as Cannabis flowers, Cannabis extracts and finished drugs with defined APIs on the other. The forecast is based on a linear trend extrapolation and an exponential trend extrapolation. Pos- sible frictions caused by legal and/or regulatory interventions are also considered and explained. In addition, the coverage rate of the population is considered in relation to the coverage rate in countries with a longer history of medical Cannabis and the further development of the cover- age rate in Germany is forecast. Reflections on the future price development in the different market segments complete the report. The Business Report - Medical Cannabis in Germany is provided on the one hand as a classic printed version. On the other hand, the current development towards digitalisation will be con- sidered and consequently a digital and an internet version of the Business Report will be made available. Since this report is based on a large amount of rapidly changing market data, it is planned to update the data periodically for the digital and internet versions, approx. every 6 months. We wish the interested readers interesting insights into the many facets of an exciting and new market, important findings and "insights" for their business interests and a good basis for strate- gic business decisions. Hamburg, April 2020 Dr Klaus-Jürgen Preuß, M.D. PD Dr Christoph von Rothkirch. Ph. D.